Press Releases Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-13 pm EDT			5-day change	1st Jan Change
14.20 ^USD	-0.70%		+0.57%	+47.76%

Feb. 27	Barrington Adjusts Price Target on Anika Therapeutics to $17 From $16, Maintains Outperform Rating	MT
Feb. 27	B. Riley Adjusts Price Target on Anika Therapeutics to $18 From $16, Maintains Buy Rating	MT

Press Releases

Feb. 26	Anika: Q4 Earnings Snapshot	AQ
Feb. 26	Anika Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
Feb. 18	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference	GL
Feb. 12	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026	GL
Jan. 08	Anika Therapeutics Announces Leadership Transition	GL
Nov. 05	Anika: Q3 Earnings Snapshot	AQ
Nov. 05	Anika Reports Third Quarter 2025 Financial Results	AQ
Nov. 05	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study	GL
25-10-23	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025	GL
25-09-08	Anika Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	AQ
25-09-05	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
25-07-30	Anika: Q2 Earnings Snapshot	AQ
25-07-30	Anika Reports Second Quarter 2025 Financial Results	AQ
25-07-30	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update	GL
25-07-16	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025	GL
25-07-03	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
25-06-05	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
25-05-12	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
25-05-12	Anika Reports First Quarter 2025 Financial Results	AQ
25-05-09	Anika: Q1 Earnings Snapshot	AQ
25-05-09	Anika Reports First Quarter 2025 Financial Results	AQ
25-05-07	Anika to Participate in the Sidoti Virtual Investor Conference	GL
25-04-29	Anika Therapeutics : 2025 Proxy Statement	PU
25-04-25	Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025	GL
25-04-07	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL